Glutathione IVs: FDA Recalls and CDC Investigation Raise Red Flags for Wellness Treatments

Glutathione is an antioxidant that occurs naturally in the body. It is also sold as an oral dietary supplement and is promoted for things such as energy, “detoxification,” immune support and skin brightening.

There are no FDA-approved glutathione products in the United States. Injectable glutathione is therefore not an FDA-approved drug treatment. Instead, some injectable products are prepared by compounding pharmacies.

That distinction matters.

FDA-approved drugs undergo FDA review before marketing. Compounded drugs generally do not undergo FDA premarket review for safety, effectiveness and quality.

That doesn't mean compounded drugs are automatically dangerous. Compounding can serve legitimate medical needs. But it does mean the quality of the particular product—and how it was made—matters enormously.

The current investigation centers on endotoxins.

Endotoxins are substances associated with certain bacteria. They can contaminate injectable medicines when appropriate quality controls aren't followed.

When significant amounts enter the bloodstream, the result can be dramatic: fever, chills, body aches, headache, nausea, dizziness and low blood pressure. Severe reactions can require emergency treatment.

The CDC says the illnesses currently under investigation are likely linked to elevated endotoxin levels in the injected products.

The investigation began after Texas health officials notified the CDC in July about patients who became ill after receiving IV glutathione at an outpatient wellness clinic.

Since then, the CDC has received reports involving more than 25 people in Texas, Washington, Florida and New York.

At least three people were hospitalized. All three had received glutathione intravenously, and one became critically ill.

The CDC says all of the glutathione injections associated with these illnesses were compounded using glutathione ingredients intended for dietary supplements, rather than ingredients appropriate for sterile injectable drugs.

That's a crucial point.

On August 27, the FDA issued a specific warning to compounders: dietary-supplement-grade glutathione should not be used to make injectable drugs.

The FDA said it was aware of adverse events involving at least 30 patients after IV glutathione, including fever, chills, pain, dizziness, signs of shock and sepsis-like symptoms. Some patients were hospitalized.

The agency said the glutathione had been obtained by different compounding pharmacies from the same supplier and was labeled dietary-supplement grade.

FDA explained that ingredients intended for dietary supplements may contain impurities or contaminants—including endotoxins—that make them inappropriate for sterile injectable drugs.

The FDA also says it warned about essentially the same type of problem back in 2019.

So this isn't a completely new safety concern.

On October 1, Greenwich Rx, a 503A compounding pharmacy in Texas, announced a voluntary nationwide recall of specific lots of compounded glutathione because of potential elevated endotoxin levels. FDA posted the recall the same day.

The recalled product is:

Glutathione Injection, 200 mg/mL, 10-mL multidose vial

It was intended for subcutaneous injection, not IV administration.

The affected lots are:

• 0060-062426-1
• 0060-062726-1
• 0060-070926-1
• 0060-071426-1
• 0060-071426-2
• 0060-072026-1
• 0060-072726-1
• 0060-072926-1
• 0060-073126-1
• 0060-080426-1

The product was distributed nationwide between June 26 and September 21, 2026.

Greenwich Rx reported two patients who required emergency-department care after receiving a glutathione product intravenously that was not formulated for IV use.

The FDA says injectable products with elevated endotoxin levels can cause serious medical events, including fever, low blood pressure, inflammatory reactions, anaphylactic shock and potentially death.

Other 2026 recalls include:

Victory Medical Center Pharmacy recalled certain compounded glutathione lots after testing identified elevated bacterial endotoxin levels. Reported adverse events included fever, chills, severe headache, nausea, vomiting, rapid heart rate, blood-pressure changes and body aches.

Optimal Balance Pharmacy recalled a lot of compounded glutathione after finding elevated bacterial endotoxin levels. Reported reactions included fever, chills, severe headache, nausea, vomiting, pain and symptoms consistent with an allergic reaction.

Centric Compounding recalled six lots of glutathione and other injectable products after finding that the glutathione API contained elevated endotoxin levels. The pharmacy reported nine cases involving symptoms including fever, chills, chest pain, nausea/vomiting, headache and malaise.

This makes the current situation considerably more significant than a single isolated product recall.

This is where it's important not to get carried away.

Glutathione is heavily promoted in some wellness and longevity settings. But the evidence that IV glutathione provides meaningful anti-aging or longevity benefits is not established.

That doesn't mean glutathione has no biological effects. It is an important antioxidant in the body.

It means something more basic:

There is a big difference between a substance having an interesting biological function and proving that injecting it into otherwise healthy people makes them live longer, age better or become healthier.

The current safety investigation doesn't prove that glutathione itself is ineffective.

It does, however, raise an uncomfortable question:

How much risk should you accept for a treatment whose benefits may be uncertain?

That's especially worth considering when the treatment involves putting a compounded drug directly into your bloodstream.

If you're considering glutathione—or another compounded IV “wellness” treatment—don't be afraid to ask the clinic some very specific questions:

1. Is this an FDA-approved drug for the purpose I'm being offered it for?

If not, ask what evidence supports the treatment.

2. Who compounded the product?

Get the name of the pharmacy rather than simply the name of the clinic.

3. Was the ingredient specifically manufactured for injectable use?

For glutathione, this is particularly important right now.

4. Is the product intended for IV administration?

The Greenwich recall illustrates why this matters. A product intended for one route of administration should not simply be substituted for an IV product.

5. Can I see the lot number?

If there is a recall, you'll need the actual lot number to determine whether your product is affected.

6. What happens if I have a reaction?

A legitimate clinic should have a clear answer about who manages complications and where emergency care is available.

Don't panic.

The CDC's investigation does not mean everyone who received injectable glutathione will become sick.

But if you have a recalled product, don't use it. Contact the pharmacy or prescribing healthcare professional for instructions.

And if you've recently received an injection and develop symptoms such as fever, chills, severe headache, vomiting, dizziness, low blood pressure or other concerning symptoms, seek medical attention promptly.

The CDC and FDA also encourage reporting suspected adverse reactions to the FDA's MedWatch program.

Glutathione isn't a dangerous substance simply because it's glutathione—and compounded drugs aren't automatically bad. But injectable glutathione deserves extra caution right now.

The CDC is investigating illnesses involving more than 25 people in four states. Multiple pharmacies have recalled injectable glutathione because of elevated endotoxins, and the FDA has warned compounders not to use dietary-supplement-grade glutathione to make injectable drugs.

Before paying for an IV wellness treatment, know what you're getting, who made it, whether the ingredient was intended for injection, and what evidence shows the treatment is worth the risk.

When someone is selling you better health, asking questions isn't being difficult. It's being a watchdog.